News | Cath Lab | August 28, 2015

Philips Showcases Integrated Cardiology Solutions for Minimally Invasive Procedures at ESC

iFR, FFR, Philips, Volcano

August 28, 2015 — Philips Healthcare is showcasing its latest cardiology solutions at the European Society of Cardiology (ESC) Congress 2015. Solutions include Heart ModelA.I., EchoNavigator and IntelliSpace Cardiovascular, that connect people and technology with care protocols to assist diagnosis, guide treatment and enable home care.

The vendor said its products offer a holistic approach to cardiovascular care, featuring digital tools and capabilities for image guided therapy and ultrasound, intravascular imaging and sensing, treatment, patient monitoring, healthcare IT and advanced software applications driving advancements in predictive and precision medicine in cardiovascular care.

"Holistic cardiovascular care looks beyond the disease to understand what really matters for all involved along the patient journey," said Bert van Meurs, general manager, image-guided therapy for Philips. "Our patient-centric solutions enable novel and effective minimally invasive procedures to diagnose and treat cardiovascular disease. These solutions also support physicians when assessing disease states, help decide and guide the right treatment and confirm whether interventions were successful. In addition, our recent acquisition of Volcano will increase our capabilities to deliver this support to both physicians and patients."

Philips' newest ultrasound technology cardiac tool, HeartModelA.I., brings automated 3-D views, robust reproducibility and advanced quantification to cardiac ultrasound imaging, will make its European debut. Philips will also offer demonstrations at the booth of its advanced imaging and ultrasound solutions designed for every step of the patient journey, including:

HeartModel - part of a suite of new tools and technologies available on Philips' EPIQ Ultrasound system designed to enhance automation and reproducibility, and helps to address some of the most critical strains on overburdened hospitals and healthcare systems challenged to provide higher quality care at lower costs

• IntelliSpace Cardiovascular — this workspace gives access to the full range of images and includes a cardiac history timeline to provide a comprehensive overview of the patients' care along the health continuum

Minicare 1-20 Acute — A user-friendly handheld point-of-care blood testing platform that speeds up clinical diagnosis by providing results within minutes

EchoNavigator — Fuses live 3-D TEE and X-ray in real time to provide image guidance in the 3-D space, supporting physicians in complex structural heart procedures to decide, guide and confirm the optimal treatment path, enabling better patient outcomes and more cost effective care

• AlluraClarity — simplifies procedures and improves workflow, while delivering excellent image quality at a lower dose

Volcano IVUS (intravascular ultrasound) — provides detailed and accurate measurements of the vessel and over a wide range of clinical studies has been shown to help ensure accurate stent expansion and apposition and a reduced need for x-ray imaging

Volcano iFR Scout — pullback technology that reveals the physiologic profile of the entire vessel and is optimized to assess serial lesions and diffuse coronary disease enabling physicians to make informed treatment decisions

For more information: www.philips.com/esc

Related Content

Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Recent Acquisitions Eroding Prices in Billion Dollar European Interventional Cardiology cath lab Market.
Feature | Cath Lab | May 07, 2018 | Simon Trinh and Jeffrey Wong
The European interventional cardiology market is currently valued at nearly $1.4 billion.
Videos | Cath Lab | May 07, 2018
Imran Ahmad, M.D., medical director of interventional cardiology, explains some of the new technologies his labs have
360 Photos | Cath Lab | April 20, 2018
A 360 degree view of the newest cath lab at Northwestern Medicine Central DuPage Hospital in Winfield, Ill., located
SCAI Announces Global Lecture Series for 2018 Scientific Sessions
News | Cath Lab | April 18, 2018
Many of the world’s leading interventional cardiologists and cardiovascular professionals will convene in San Diego,...
Serial coronary angiograms of the representative case treated with shockwave intravascular lithotripsy.

Figure 1. Serial coronary angiograms of the representative case treated with shockwave intravascular lithotripsy.

Feature | Cath Lab | April 16, 2018 | Azeem Latib, M.D.
Over the last decade, there have been considerable developments in procedural techniques and technology facilitating
Overlay Init